Connor, Clark & Lunn Investment Management Ltd. Catalyst Biosciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$4.93 - $7.15 $223,895 - $324,717
-45,415 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$4.55 - $7.29 $6,370 - $10,206
1,400 Added 3.18%
45,415 $287,000
Q3 2020

Nov 12, 2020
SELL
$4.22 - $6.04 $75,407 - $107,928
-17,869 Reduced 28.87%
44,015 $189,000
Q2 2020

Aug 13, 2020
SELL
$3.76 - $8.01 $7,926 - $16,885
-2,108 Reduced 3.29%
61,884 $363,000
Q1 2020

May 13, 2020
BUY
$3.5 - $8.51 $223,972 - $544,571
63,992 New
63,992 $279,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email